Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000229750

Medchemexpress LLC ONO-0300302 10mg | 856689-51-5 | 10 MG
SDP

Catalog No. 5000229750
Encompass_Preferred

ONO-0300302 is an orally active, potent lysophosphatidic acid receptor 1 (LPA1) antagonist used in preclinical research, including models of benign prostatic hyperplasia. It is a slow tight-binding inhibitor with reported IC50 0.086 μM and Kd 0.34 nM, and is supplied at high purity for experimental use.

  • Orally active LPA1 antagonist with IC50 0.086 μM.
  • Slow, tight-binding inhibitor with a reported Kd of 0.34 nM (37 °C, 2 h).
  • High supplied purity, suitable for research applications.
  • Available in small pack sizes for preclinical experiments.
  • Chemical formula C29H35NO5; molecular weight 477.59 g·mol⁻1.

Catalog No. 50-002-29750 Supplier Medchemexpress LLC Supplier No. HY11545010MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

ONO-0300302 is an orally active, potent lysophosphatidic acid receptor 1 (LPA1) antagonist used in preclinical research, including models of benign prostatic hyperplasia. It is a slow tight-binding inhibitor with reported IC50 0.086 μM and Kd 0.34 nM, and is supplied at high purity for experimental use.

  • Orally active LPA1 antagonist with IC50 0.086 μM.
  • Slow, tight-binding inhibitor with a reported Kd of 0.34 nM (37 °C, 2 h).
  • High supplied purity, suitable for research applications.
  • Available in small pack sizes for preclinical experiments.
  • Chemical formula C29H35NO5; molecular weight 477.59 g·mol⁻1.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.